Question: On 17 September 2021 which of the following organisation has organised the third edition of Life Sciences Conclave?
a) CII
b) CSIR
c) IISc
d) TIFR
Answer: (a)
Related Facts:-
- On 17 September 2021; CII organized the third edition of Life Sciences Conclave.
- Life Sciences Conclave also provides the necessary platform for stakeholders across the world to converge and embed their ideas.
- The Indian Life Sciences industry is paving the way for future growth in terms of meeting the domestic needs.
- This industry is also establishing the nation as a leader in the global life sciences landscape.
- There are still several challenges in this field that need to be addressed and it is of fundamental importance.
- There is still a grave need to re-strategize the restoration of India’s position in the pharmaceutical and biotechnology landscape.
- This platform seeks to curate and create an environment conducive to help build a better future and achieve the targets the nation has set for itself.
- Principal Scientific Adviser, Government of India, Prof. K Vijay Raghavan was present at the inaugural session of the CII Life Sciences Conclave.
- He stated that reform is needed in the space of ease of doing science, regulation, university functioning in research and industry academia linkages.
- Prof. Raghavan expressed that there is an extraordinary desire to do high end research that is globally competitive.
- He said that the industry has no shortage of capital but a shortage of risk capital.
- He is of the view that there is a need to connect our lab ecosystem to our industry and bring research into our broader ecosystem.
- Our population, network of labs and the fundamental simplicity of research that is undertaken here will help India grow as compared to similarly placed countries.
- Dr Renu Swarup, Secretary, Department of Biotechnology & Department of Science and Technology, Ministry of Science & Technology
- According to Dr Renu Swarup today we have been able to see breakthrough in silos and the boundaries have gotten blurred between academia, industry and startups.
- Dr Renu Swarup is the Secretary, Department of Biotechnology & Department of Science and Technology, Ministry of Science & Technology
- Moving ahead we can hope India will not just be the pharmacy of the world but also the research lab of the world.
- There is a need to create an industry strategized research partnership platform.
- The bio-strategy document is in place that will lead India to become a USD 150 billion market by 2025.
- CII on this occasion also launched the report titled as-Taking India’s Life Sciences to the Global Stage – Make in India” to fuel 4x growth in Biosimilars and Vaccines by 2026.”
- We now need to focus on how ways to encourage new IP generation and new innovative research, this will require industry collaborations with both academia and startups.
- Our focus should be on achieving scalability that is matched with sustainability, and we will at least 10,000 startups in the next 5 years.
- At the Valedictory Session, Ms S Aparna Secretary, Department of Pharmaceuticals said that in the last 5-10 years India has become a favored destination for pharma companies.
- There is a global move towards the greater diversification in this field.